JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Franklin Rosenfeldt
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenfeldt, F.
Right arrow Articles by Roubos, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenfeldt, F.
Right arrow Articles by Roubos, N.
Related Collections
Right arrow Cardiac - physiology
Right arrow Coronary disease
Right arrowRelated Article

J Thorac Cardiovasc Surg 2007;133:1118
© 2007 The American Association for Thoracic Surgery

Letter to the Editor

Vein graft neointimal hyperplasia: Prevention is better than cure

Franklin Rosenfeldt, FRACSa, Guo Wei He, MD, DScb, Nick Roubos, MB, BS, BMedScic

a Department of Cardiothoracic Surgery, Monash University, Department of Surgery, Alfred Hospital and the Baker Heart Research Institute, Melbourne, Australia
b Department of Surgery, The Chinese University of Hong Kong
c Department of Cardiothoracic Surgery, Alfred Hospital Melbourne, Melbourne, Australia

The first 20% of the full text of this article appears below.

To the Editor:

We read with interest the article by Thomas Schachner.1Go This review was an excellent description of the multiple factors involved in the initiation and progression of neointimal hyperplasia in vein grafts during coronary bypass surgery. Clearly much has been learned in recent years about the type and origin of the cells composing the hyperplastic tissue and other various factors involved in the hyperplastic process. Schachner has proposed multiple pharmacologic strategies to reduce this hyperplastic process.

However, we . . . [Full Text of this Article]


Related Article

Reply to the Editor
Thomas Schachner
J. Thorac. Cardiovasc. Surg. 2007 133: 1119. [Extract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.